These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10557569)

  • 41. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
    Jones RW
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New performance of biosensor technology for Alzheimer's disease drugs: in vitro comparison of tacrine and 7-methoxytacrine.
    Pohanka M; Kuca K; Kassa J
    Neuro Endocrinol Lett; 2008 Oct; 29(5):755-8. PubMed ID: 18987590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concern over memory drugs.
    Elder Care; 1997; 9(2):34. PubMed ID: 9180463
    [No Abstract]   [Full Text] [Related]  

  • 45. [Alzheimer's disease].
    Giménez-Roldán S
    Rev Neurol; 1995; 23(119):96-102. PubMed ID: 8548651
    [No Abstract]   [Full Text] [Related]  

  • 46. Tacrine treatment of Alzheimer's disease: many expectations, few certainties.
    Malaguarnera M; Pistone G; Vinci M; Motta M; di Fazio I; Rampello L
    Neuropsychobiology; 1998 Nov; 38(4):226-31. PubMed ID: 9813462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of tacrine in nursing home residents with Alzheimer's dementia.
    Woo JK; Lantz MS; Marchello V; Libow LS
    J Am Geriatr Soc; 1996 Nov; 44(11):1411-2. PubMed ID: 8909368
    [No Abstract]   [Full Text] [Related]  

  • 48. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders.
    Amar K; Wilcock GK; Scot M; Lewis T
    Age Ageing; 1997 Jan; 26(1):25-9. PubMed ID: 9143434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatments for Alzheimer's disease.
    Harvey R; Rossor M
    Practitioner; 1995 Jul; 239(1552):440-3. PubMed ID: 7659667
    [No Abstract]   [Full Text] [Related]  

  • 51. THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease.
    Riekkinen P; Riekkinen M
    Neuropsychopharmacology; 1999 Apr; 20(4):357-64. PubMed ID: 10088136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methodology, results and quality of clinical trials of tacrine in the treatment of Alzheimer's disease: a systematic review of the literature.
    Arrieta JL; Artalejo FR
    Age Ageing; 1998 Mar; 27(2):161-79. PubMed ID: 16296676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease.
    Patocka J; Jun D; Kuca K
    Curr Drug Metab; 2008 May; 9(4):332-5. PubMed ID: 18473751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benzodiazepine utilization patterns in Alzheimer's disease patients.
    Lagnaoui R; Moore N; Moride Y; Miremont-Salamé G; Bégaud B
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):511-5. PubMed ID: 14513664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of tacrine: clinical trials, treatment IND, and postmarketing experience.
    Gracon SI; Knapp MJ; Berghoff WG; Pierce M; DeJong R; Lobbestael SJ; Symons J; Dombey SL; Luscombe FA; Kraemer D
    Alzheimer Dis Assoc Disord; 1998 Jun; 12(2):93-101. PubMed ID: 9651138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's and Cognex.
    Steel JG
    N C Med J; 1995 Feb; 56(2):72-3. PubMed ID: 7741935
    [No Abstract]   [Full Text] [Related]  

  • 60. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.